Inventor
STEVENS BRENDA L
US15 patents
⚠️ This page may combine multiple inventors who share the name “STEVENS BRENDA L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS10251945B2Apr 9, 2019
Anti-ICOS agonist antibodies and uses thereof
BRISTOL MYERS SQUIBB CO20 citations93
US8945553B2Feb 3, 2015
Bispecific antibodies to IL-23 and IL-17A/F
BRISTOL MYERS SQUIBB CO16 citations91
US9708401B2Jul 18, 2017
IL-17A/F cross-reactive monoclonal antibodies and methods of using the same
BRISTOL MYERS SQUIBB CO3 citations84
US11207391B2Dec 28, 2021
Anti-ICOS agonist antibodies and uses thereof
BRISTOL MYERS SQUIBB CO4 citations82
US10898556B2Jan 26, 2021
Anti-ICOS agonist antibodies and uses thereof
BRISTOL MYERS SQUIBB CO7 citations82
US10493140B2Dec 3, 2019
Anti-ICOS agonist antibodies and uses thereof
BRISTOL MYERS SQUIBB CO3 citations82
US11254740B2Feb 22, 2022
Methods of treatment using IL-23p19 monoclonal antibodies
BRISTOL MYERS SQUIBB CO0 citations62
US11952427B2Apr 9, 2024
Anti-CD40 antibodies and uses thereof
BRISTOL MYERS SQUIBB CO0 citations61
US11529399B2Dec 20, 2022
Anti-ICOS agonist antibodies and uses thereof
BRISTOL MYERS SQUIBB CO0 citations61
US11306149B2Apr 19, 2022
Anti-CD40 antibodies and uses thereof
BRISTOL MYERS SQUIBB CO1 citations61
US9783606B2Oct 10, 2017
Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23p19 antibodies
BRISTOL MYERS SQUIBB CO1 citations61
US10358489B2Jul 23, 2019
IL-23p19 monoclonal antibodies
BRISTOL MYERS SQUIBB CO0 citations52
US10358490B2Jul 23, 2019
Methods of treating inflammation with IL-17A/F and IL-23P19 bispecific antibodies
BRISTOL MYERS SQUIBB CO0 citations51
US10844130B2Nov 24, 2020
Nucleic acids encoding an anti-CD40 antibody
BRISTOL MYERS SQUIBB CO0 citations50